Trial Profile
A study to evaluate the effect of UGT1A1*28 Polymorphism on Raltegravir metabolism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Pharmacokinetics
- 02 Mar 2016 New trial record